Deal Snapshot
TUNISIAN DRUGMAKER MEDIS ACQUIRES WINTHROP PHARMA SENEGAL FROM FRANCE´S SANOFI
Thursday 20 April 2017

Tunisian pharmaceutical company MédiS has acquired Winthrop Pharma Senegal from French drugmaker Sanofi (NYSE: SNY), the company said. MédiS is a portfolio company of UK-based growth markets investor Actis. Terms of the deal were not disclosed.
Actis invested in MédiS at the end of August 2016 with the vision to work alongside the founder Dr Lassaad Boujbel and management to build a leading pan- African and Middle East player. Through this acquisition, MédiS aims to actively develop the business in Francophone Sub-Saharan Africa from a Senegalese base.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 20/04/2017
Target: Pharma Senegal
Country: Senegal
Sector: Pharmaceuticals
Type: LBO
Financing:
Status: Closed
Vendor: Sanofi
Buyer: M, ├ędiS
Comment:
Terms of the deal were not disclosed

Options